CELCUITY
Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies.
CELCUITY
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
Hamel, Minnesota, United States
Country:
United States
Website Url:
http://www.celcuity.com
Total Employee:
11+
Status:
Active
Contact:
763-473-0341
Total Funding:
143.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Cellics Therapeutics
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Celcuity
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Celcuity
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Celcuity
Commodore Capital
Commodore Capital investment in Post-IPO Equity - Celcuity
Soleus Capital
Soleus Capital investment in Post-IPO Equity - Celcuity
Brian Sullivan
Brian Sullivan investment in Post-IPO Equity - Celcuity
Brightstone Venture Capital
Brightstone Venture Capital investment in Series A - Celcuity
Official Site Inspections
http://www.celcuity.com Semrush global rank: 3.33 M Semrush visits lastest month: 4.81 K
- Host name: 164.77.69.34.bc.googleusercontent.com
- IP address: 34.69.77.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
